Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.
Schroder UK Public Private Trust, the investment vehicle operated by asset manager Schroder, has dumped its shareholding in Carrick Therapeutics, an Ireland-based biopharmaceutical spinout of University of Cambridge, according to the Irish Times.
The trust sold its stake, valued at £18.2m ($23.4m) in September 2020, to venture capital firm Rosetta Capital as part of a deal that included six other holdings. Rosetta paid $72.4m for the package deal, representing a 22% aggregate discount.
Founded in 2015, Carrick Therapeutics…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
